The chairman of Apotex, the largest
producer of generic drugs in Canada, came under fire recently for helping to organize a $ 500 - per - ticket pay - for - access fundraiser for the party.
Not exact matches
The two heavyweight CEOs were there — along with Jeff Watson, the president
of Apotex, Canada's largest
generic -
drug producer — to present a plan calling for a vast expansion
of the role pharmacists play in the Canadian health - care system.
FILE PHOTO: A building belonging to
generic drug producer Teva, Israel's largest company with a market value
of about $ 57 billion, is seen in Jerusalem March 23, 2010.
The legal battle began after AstraZeneca filed a patent related to the
drug, but
generic pharmaceutical
producer Apotex applied to the federal Minister
of Health to be able to sell its
generic version.
Pay - for - delay («PFD») agreements are agreements that are intended to delay the market entry
of generic manufacturers with
generic drugs in exchange for payments made by original pharmaceutical
producers (i.e., holders
of patents for an original branded
drug).